Manfred Hans Philipp

Title: Manfred Hans Philipp: Innovator in Pharmaceutical Compositions

Introduction

Manfred Hans Philipp is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for trypsin-like enzymes. With a total of 2 patents, his work has implications for therapeutic methods aimed at inhibiting thrombin.

Latest Patents

Philipp's latest patents focus on pharmaceutical compositions that comprise specific compounds designed to inhibit thrombin. The first patent details inhibitors of trypsin-like enzymes, featuring compounds of the formula where X is either hydrogen or an N-protecting group, Y consists of 1-10 alpha-amino acids, and R is a C1-4 alkyl group. The second patent similarly addresses inhibitors of trypsin-like enzymes, with a focus on compounds where X equals hydrogen or an N-protecting group, Y is Phe-Pro, and R is also a C1-4 alkyl group. Both patents highlight the potential therapeutic applications of these compounds.

Career Highlights

Throughout his career, Philipp has worked with esteemed organizations such as the Thrombosis Research Institute and Trigen GmbH. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Philipp has collaborated with notable professionals in his field, including Goran Karl Claeson and Rainer Metternich. These collaborations have further enriched his research and development efforts.

Conclusion

Manfred Hans Philipp's contributions to pharmaceutical innovations, particularly in the area of thrombin inhibition, underscore his role as a significant inventor in the industry. His patents reflect a commitment to advancing therapeutic methods that can have a profound impact on healthcare.